MGMR - Overview: Myasthenia Gravis Evaluation with Muscle-Specific Kinase (MuSK) Reflex, Serum
Diagnosing autoimmune myasthenia gravis (MG) in adults and children Distinguishing autoimmune from congenital MG in adults and children or other acquired forms of neuromuscular junction transmission disorders Establishing a quantitative...
TLTE4 - Overview: Leukotriene E4, 24 Hour, Urine
Aiding in the evaluation of patients at-risk for mast cell activation syndrome (eg, systemic mastocytosis, IgE-mediated allergies, or aspirin-exacerbated respiratory disease) using 24-hour urine collections
INFXR - Overview: Infliximab Quantitation with Reflex to Antibodies to Infliximab, Serum
Trough level quantitation for evaluation of patients undergoing therapy with infliximab, with signs and symptoms of loss of response to therapy.
Only indicated for formalin-fixed paraffin-embedded specimens from patients diagnosed with large B-cell lymphoma
MGLE - Overview: Myasthenia Gravis/Lambert-Eaton Myasthenic Syndrome Evaluation, Serum
Confirming the autoimmune basis of a defect in neuromuscular transmission (eg, myasthenia gravis [MG], Lambert-Eaton myasthenic syndrome [LEMS]) Distinguishing LEMS from autoimmune forms of MG Providing a quantitative autoantibody...
SMN1Z - Overview: SMN1 Gene, Full Gene Analysis, Varies
Confirming a diagnosis of spinal muscular atrophy due to nucleotide variants in SMN1 gene Second-tier carrier screening when there is a family history of spinal muscular atrophy, but an affected individual is not available for testing, or...
SQTSG - Overview: Short QT Syndrome Gene Panel, Varies
Providing a genetic evaluation for patients with a personal or family history suggestive of short QT syndrome Establishing a diagnosis of short QT syndrome
SSAB - Overview: SS-A and SS-B Antibodies, IgG, Serum
Evaluating patients with signs and symptoms of a connective tissue disease in whom the test for antinuclear antibodies is positive, especially those with signs and symptoms consistent with Sjogren syndrome or lupus erythematosus This test...
NMS1 - Overview: Necrotizing Myopathy Evaluation, Serum
Evaluating patients with suspected necrotizing autoimmune myopathy
PSTF - Overview: Protein S Antigen, Plasma
Investigation of patients with a history of thrombosis
Register today for Classical Hematology 2023 - Insights
Taking place on October 3–4, 2023, in Rochester, Minnesota, the Classical Hematology 2023 conference focuses on addressing the evaluation of frequently encountered blood count abnormalities. The conference...
Visit Mayo Clinic Laboratories at Medlab Middle East 2023 - Insights
announce our participation in Medlab Middle East 2023, a medical conference and exhibition taking place in Dubai, United Arab Emirates, Feb. 6–9, 2023....
Top 5 Mayo Clinic Laboratories advancements in 2024 - Insights
Five of the most significant advancements from Mayo Clinic Laboratories in 2024 to enhance diagnostics and patient care globally....
Visit Mayo Clinic Laboratories at Medlab Middle East 2024 - Insights
announce our participation in Medlab Middle East 2024, a medical conference and exhibition taking place in Dubai, United Arab Emirates, Feb. 5–8, 2024....
Managing Compliance in Preparation for 2025 Updates - Insights
With updates expected to federal compliance guidance for laboratories in 2025, now is a great time to revisit existing guidelines and plans....